Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 03:22PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.45 Insider Own29.44% Shs Outstand10.40M Perf Week82.21%
Market Cap6.79M Forward P/E- EPS next Y-1.35 Insider Trans0.32% Shs Float7.74M Perf Month4.63%
Income-14.10M PEG- EPS next Q-0.41 Inst Own11.98% Short Float0.80% Perf Quarter-76.71%
Sales5.44M P/S1.25 EPS this Y-10.16% Inst Trans-11.91% Short Ratio0.18 Perf Half Y-82.70%
Book/sh0.28 P/B2.23 EPS next Y4.26% ROA- Short Interest0.06M Perf Year-84.70%
Cash/sh0.53 P/C1.16 EPS next 5Y- ROE- 52W Range0.33 - 5.39 Perf YTD-82.93%
Dividend Est.- P/FCF- EPS past 5Y64.46% ROI-463.78% 52W High-88.51% Beta0.54
Dividend TTM- Quick Ratio0.85 Sales past 5Y49.19% Gross Margin89.78% 52W Low85.53% ATR (14)0.13
Dividend Ex-DateDec 19, 2022 Current Ratio0.85 EPS Y/Y TTM93.06% Oper. Margin-288.92% RSI (14)47.69 Volatility29.68% 22.67%
Employees11 Debt/Eq0.46 Sales Y/Y TTM- Profit Margin-259.08% Recom1.00 Target Price10.75
Option/ShortNo / No LT Debt/Eq0.05 EPS Q/Q88.23% Payout- Rel Volume2.53 Prev Close0.53
Sales Surprise-100.00% EPS Surprise68.97% Sales Q/Q-100.00% EarningsMar 21 AMC Avg Volume350.01K Price0.62
SMA2024.68% SMA50-45.37% SMA200-75.22% Trades Volume804,747 Change17.55%
Apr-08-24 04:01PM
Mar-21-24 10:54PM
Mar-12-24 08:00AM
Feb-29-24 09:36AM
08:30AM Loading…
Feb-22-24 08:30AM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-17-24 08:30AM
Jan-04-24 08:30AM
Dec-15-23 08:35AM
Dec-13-23 08:30AM
Dec-12-23 01:02PM
08:30AM Loading…
Nov-28-23 08:30AM
Nov-09-23 08:30AM
Nov-06-23 08:30AM
Nov-03-23 04:07PM
Oct-17-23 08:30AM
Oct-12-23 10:19AM
Oct-09-23 12:10PM
Oct-05-23 04:09PM
Oct-04-23 08:30AM
Oct-03-23 08:30AM
Sep-28-23 09:30AM
09:30AM Loading…
Sep-25-23 09:30AM
Sep-18-23 09:30AM
Sep-16-23 09:00PM
Aug-31-23 09:30AM
Aug-16-23 06:44AM
Aug-11-23 04:07PM
Aug-04-23 06:23AM
Aug-03-23 08:03AM
Jul-26-23 01:30PM
Jun-29-23 06:30AM
Jun-28-23 06:30AM
Jun-20-23 05:50AM
May-24-23 06:30AM
May-23-23 06:30AM
May-11-23 05:39PM
Apr-24-23 04:01PM
Apr-20-23 08:38AM
Apr-17-23 06:30AM
Apr-12-23 06:30AM
Apr-03-23 06:30AM
Mar-31-23 04:01PM
Mar-22-23 06:30AM
Mar-08-23 06:30AM
Mar-06-23 06:30AM
Mar-01-23 06:30AM
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bartoszek Raymond J.DirectorDec 06 '23Buy4.502501,12517,206Dec 06 06:21 PM
Bartoszek Raymond J.DirectorDec 05 '23Buy4.501,0004,50016,956Dec 06 06:21 PM
Bartoszek Raymond J.DirectorDec 04 '23Buy4.331,0004,32515,956Dec 06 06:21 PM
Iadonato ShawnChief Executive OfficerNov 29 '23Buy3.514,10014,403675,230Nov 30 05:21 PM
PHILIPS CRAIG W.PresidentNov 28 '23Buy3.273,0009,81260,811Nov 30 05:27 PM
Iadonato ShawnChief Executive OfficerNov 28 '23Buy3.339002,995671,130Nov 30 05:21 PM
Foote Marion RDirectorOct 11 '23Option Exercise0.144,443622143,204Oct 12 04:25 PM
PHILIPS CRAIG W.PresidentSep 21 '23Buy2.402,9006,97057,811Sep 21 04:58 PM
Iadonato ShawnChief Executive OfficerSep 20 '23Buy2.5010,00025,042670,230Sep 21 04:57 PM
Kenny PaulineGeneral Counsel & SecretarySep 20 '23Buy2.581,5003,87018,448Sep 21 04:57 PM
PHILIPS CRAIG W.PresidentSep 20 '23Buy2.546001,52554,911Sep 21 04:58 PM
Bartoszek Raymond J.DirectorSep 19 '23Buy2.372,0004,74514,956Sep 21 04:56 PM
Baker KeithChief Financial OfficerSep 18 '23Buy2.135,00010,67216,880Sep 19 05:03 PM
Bartoszek Raymond J.DirectorSep 18 '23Buy2.082,5005,20012,956Sep 19 05:02 PM
Bartoszek Raymond J.DirectorSep 15 '23Buy2.185001,09010,456Sep 19 05:02 PM
Guillaudeux ThierryChief Scientific OfficerSep 14 '23Buy2.0010,00020,00021,696Sep 15 06:49 PM
Baker KeithChief Financial OfficerJun 16 '23Buy2.925,00014,60011,880Jun 16 04:28 PM
Bartoszek Raymond J.DirectorJun 14 '23Option Exercise0.1460,0188,403844,478Jun 16 04:29 PM
PHILIPS CRAIG W.PresidentJun 14 '23Option Exercise0.141,38219334,654Jun 16 04:31 PM
Iadonato ShawnChief Executive OfficerJun 14 '23Option Exercise0.141,382193667,669Jun 16 04:29 PM